{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:19:12Z","timestamp":1792081152258,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05563-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:07:01Z","timestamp":1751389621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and comparative analysis of PD-1\/PD-L1 inhibitor-induced pituitary dysfunction versus other pituitary disorders"],"prefix":"10.1038","volume":"15","author":[{"given":"Yan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"7","key":"5563_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","volume":"9","author":"SJ Wang","year":"2023","unstructured":"Wang, S. J., Dougan, S. K. & Dougan, M. Immune mechanisms of toxicity from checkpoint inhibitors. Trends Cancer Jul. 9 (7), 543\u2013553 (2023).","journal-title":"Trends Cancer Jul"},{"issue":"1","key":"5563_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-021-01056-8","volume":"19","author":"JA Marin-Acevedo","year":"2021","unstructured":"Marin-Acevedo, J. A., Kimbrough, E. O. & Lou, Y. Next generation of immune checkpoint inhibitors and beyond. J Hematol. Oncol. Mar. 19 (1), 45 (2021).","journal-title":"J Hematol. Oncol. Mar."},{"issue":"10304","key":"5563_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino, M. S., Larkin, J. & Long, G. V. Immune checkpoint inhibitors in melanoma. Lancet Sep. 398 (10304), 1002\u20131014 (2021).","journal-title":"Lancet Sep."},{"issue":"2","key":"5563_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.alit.2022.01.001","volume":"71","author":"N Okiyama","year":"2022","unstructured":"Okiyama, N. & Tanaka, R. Immune-related adverse events in various organs caused by immune checkpoint inhibitors. Allergol Int. Apr. 71 (2), 169\u2013178 (2022).","journal-title":"Allergol Int. Apr"},{"issue":"2","key":"5563_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow, M. A., Sidlow, R. & Hellmann, M. D. Immune-Related adverse events associated with immune checkpoint Blockade. N Engl. J. Med. Jan. 378 (2), 158\u2013168 (2018).","journal-title":"N Engl. J. Med. Jan"},{"issue":"7","key":"5563_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41574-021-00484-3","volume":"17","author":"JJ Wright","year":"2021","unstructured":"Wright, J. J., Powers, A. C. & Johnson, D. B. Endocrine toxicities of immune checkpoint inhibitors. Nat Rev. Endocrinol. Jul. 17 (7), 389\u2013399 (2021).","journal-title":"Nat Rev. Endocrinol. Jul"},{"issue":"3","key":"5563_CR7","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.beem.2022.101668","volume":"36","author":"T Mizukoshi","year":"2022","unstructured":"Mizukoshi, T., Fukuoka, H. & Takahashi, Y. Immune checkpoint inhibitor-related hypophysitis. Best Pract. Res. Clin. Endocrinol. Metab. May. 36 (3), 101668 (2022).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab. May"},{"key":"5563_CR8","doi-asserted-by":"crossref","unstructured":"Levy, M. et al. Anti-PD1 and Anti-PDL1-Induced hypophysitis: A cohort study of 17 patients with longitudinal Follow-Up. J Clin. Med. Oct. 9(10), 3280 (2020).","DOI":"10.3390\/jcm9103280"},{"issue":"230","key":"5563_CR9","first-page":"230ra245","volume":"6","author":"S Iwama","year":"2014","unstructured":"Iwama, S. et al. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med. Apr. 6 (230), 230ra245 (2014).","journal-title":"Sci Transl Med. Apr"},{"issue":"12","key":"5563_CR10","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00262-021-02955-y","volume":"70","author":"K Kanie","year":"2021","unstructured":"Kanie, K. et al. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome. Cancer Immunol. Immunother Dec. 70 (12), 3669\u20133677 (2021).","journal-title":"Cancer Immunol. Immunother Dec."},{"issue":"2","key":"5563_CR11","doi-asserted-by":"publisher","first-page":"102454","DOI":"10.1016\/j.autrev.2019.102454","volume":"19","author":"R Percik","year":"2020","unstructured":"Percik, R. et al. Isolated autoimmune adrenocorticotropic hormone deficiency: from a rare disease to the dominant cause of adrenal insufficiency related to checkpoint inhibitors. Autoimmun Rev. Feb. 19 (2), 102454 (2020).","journal-title":"Autoimmun Rev. Feb"},{"issue":"4","key":"5563_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","volume":"9","author":"M Andrioli","year":"2006","unstructured":"Andrioli, M., Pecori Giraldi, F. & Cavagnini, F. Isolated Corticotrophin deficiency. Pituitary 9 (4), 289\u2013295 (2006).","journal-title":"Pituitary"},{"issue":"3","key":"5563_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2265.1991.tb03524.x","volume":"35","author":"SM Orme","year":"1991","unstructured":"Orme, S. M. & Belchetz, P. E. Isolated ACTH deficiency. Clin Endocrinol. (Oxf) Sep. 35 (3), 213\u2013217 (1991).","journal-title":"Clin Endocrinol. (Oxf) Sep."},{"issue":"4","key":"5563_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11154-018-9480-1","volume":"19","author":"S Gubbi","year":"2018","unstructured":"Gubbi, S., Hannah-Shmouni, F., Stratakis, C. A. & Koch, C. A. Primary hypophysitis and other autoimmune disorders of the Sellar and suprasellar regions. Rev Endocr. Metab. Disord Dec. 19 (4), 335\u2013347 (2018).","journal-title":"Rev Endocr. Metab. Disord Dec."},{"issue":"6","key":"5563_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","volume":"19","author":"G Bellastella","year":"2016","unstructured":"Bellastella, G. et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary Dec. 19 (6), 625\u2013642 (2016).","journal-title":"Pituitary Dec."},{"issue":"1","key":"5563_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","volume":"5","author":"I Puzanov","year":"2017","unstructured":"Puzanov, I. et al. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of Cancer (SITC) toxicity management working group. J Immunother Cancer Nov. 5 (1), 95 (2017).","journal-title":"J Immunother Cancer Nov"},{"key":"5563_CR17","doi-asserted-by":"crossref","unstructured":"Brahmer, J. R. et al. Society for immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer Jun. 9(6), e002435 (2021).","DOI":"10.1136\/jitc-2021-002435"},{"issue":"36","key":"5563_CR18","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider, B. J. et al. Management of immune-Related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin. Oncol. Dec. 39 (36), 4073\u20134126 (2021).","journal-title":"J Clin. Oncol. Dec."},{"key":"5563_CR19","doi-asserted-by":"crossref","unstructured":"Van Mieghem, E., De Block, C. & De Herdt, C. Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease. Pituitary Dec. 27(1), 23\u201332 (2023).","DOI":"10.1007\/s11102-023-01366-9"},{"issue":"4\u20135","key":"5563_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.autrev.2014.01.021","volume":"13","author":"A Falorni","year":"2014","unstructured":"Falorni, A., Minarelli, V., Bartoloni, E., Alunno, A. & Gerli, R. Diagnosis and classification of autoimmune hypophysitis. Autoimmun Rev. Apr-May. 13 (4\u20135), 412\u2013416 (2014).","journal-title":"Autoimmun Rev. Apr-May"},{"issue":"4","key":"5563_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1507\/endocrj.EJ19-0569","volume":"67","author":"H Takagi","year":"2020","unstructured":"Takagi, H. et al. Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan endocrine society. Endocr J. Apr. 67 (4), 373\u2013378 (2020).","journal-title":"Endocr J. Apr"},{"issue":"11","key":"5563_CR22","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu, M. et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin. Endocrinol. Metab. Nov. 101 (11), 3888\u20133921 (2016).","journal-title":"J Clin. Endocrinol. Metab. Nov"},{"issue":"5","key":"5563_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin, S. et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin. Endocrinol. Metab. May. 103 (5), 1715\u20131744 (2018).","journal-title":"J Clin. Endocrinol. Metab. May"},{"issue":"11","key":"5563_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KCJ Yuen","year":"2019","unstructured":"Yuen, K. C. J. et al. American association of clinical endocrinologists and American college of endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. Nov. 25 (11), 1191\u20131232 (2019).","journal-title":"Endocr Pract. Nov"},{"issue":"3","key":"5563_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.6004\/jnccn.2022.7098","volume":"21","author":"J Johnson","year":"2023","unstructured":"Johnson, J. et al. Hypophysitis and secondary adrenal insufficiency from immune checkpoint inhibitors: diagnostic challenges and link with survival. J Natl. Compr. Canc Netw. Feb. 21 (3), 281\u2013287 (2023).","journal-title":"J Natl. Compr. Canc Netw. Feb"},{"issue":"8","key":"5563_CR26","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.autrev.2020.102590","volume":"19","author":"P Triggianese","year":"2020","unstructured":"Triggianese, P. et al. Immune checkpoint inhibitors-induced autoimmunity: the impact of gender. Autoimmun Rev. Aug. 19 (8), 102590 (2020).","journal-title":"Autoimmun Rev. Aug"},{"issue":"2","key":"5563_CR27","doi-asserted-by":"publisher","first-page":"e000779","DOI":"10.1136\/jitc-2020-000779","volume":"8","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study. J Immunother Cancer Jul. 8 (2), e000779 (2020).","journal-title":"J Immunother Cancer Jul"},{"issue":"4","key":"5563_CR28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11102-021-01141-8","volume":"24","author":"P Iglesias","year":"2021","unstructured":"Iglesias, P., S\u00e1nchez, J. C. & D\u00edez, J. J. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review. Pituitary Aug. 24 (4), 630\u2013643 (2021).","journal-title":"Pituitary Aug"},{"issue":"11","key":"5563_CR29","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1210\/jc.2014-2306","volume":"99","author":"AT Faje","year":"2014","unstructured":"Faje, A. T. et al. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin. Endocrinol. Metab. Nov. 99 (11), 4078\u20134085 (2014).","journal-title":"J Clin. Endocrinol. Metab. Nov"},{"issue":"2","key":"5563_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-14-0845","volume":"172","author":"F Albarel","year":"2015","unstructured":"Albarel, F. et al. Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma. Eur J. Endocrinol. Feb. 172 (2), 195\u2013204 (2015).","journal-title":"Eur J. Endocrinol. Feb"},{"issue":"1","key":"5563_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11102-015-0671-4","volume":"19","author":"A Faje","year":"2016","unstructured":"Faje, A. Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary Feb. 19 (1), 82\u201392 (2016).","journal-title":"Pituitary Feb"},{"issue":"4","key":"5563_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1158\/1078-0432.CCR-14-2353","volume":"21","author":"L Min","year":"2015","unstructured":"Min, L. et al. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. Feb. 21 (4), 749\u2013755 (2015).","journal-title":"Clin Cancer Res. Feb"},{"issue":"9","key":"5563_CR33","doi-asserted-by":"publisher","first-page":"103387","DOI":"10.1016\/j.autrev.2023.103387","volume":"22","author":"S Aviv-Shimoni","year":"2023","unstructured":"Aviv-Shimoni, S., Uri, I., Milloh-Raz, H. & Percik, R. Isolated autoimmune adrenocorticotropic hormone deficiency: A positive predictor of survival among cancer patients treated with checkpoint inhibitors. Autoimmun. Rev. 22 (9), 103387 (2023).","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"5563_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1055\/a-2135-7708","volume":"131","author":"C Yang","year":"2023","unstructured":"Yang, C., Li, X. & Ma, X. Idiopathic isolated adrenocorticotropic hormone deficiency: A Single-Center retrospective study. Exp Clin. Endocrinol. Diabetes Oct. 131 (10), 523\u2013531 (2023).","journal-title":"Exp Clin. Endocrinol. Diabetes Oct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05563-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:07:03Z","timestamp":1751389623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05563-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5563"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05563-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Chinese PLA General Hospital (Approval No. S2023-290-01). The Ethics Committee of Chinese PLA General Hospital waived the requirement for informed consent and Patient consent, given the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"21353"}}